Message from the Director
Lastly, I want to draw your attention to the new OWH address listed at the end of the update. OWH has moved to the FDA White Oak campus. We look forward to working with your from our new home.
Marsha Henderson, MRCP
Assistant Commissioner for Women’s Health (Acting)
OWH Outreach
Throughout National Women’s Health Week (May 9-15), the nationally-syndicated Dear Abby column announced the availability of a Health Information Kit from the OWH. With a daily readership of over 110 million, Dear Abby helped to raise awareness about the kit that included tips on managing medicines, practicing food safety, and taking care of the entire family. The free kits can be ordered through the
Federal Citizens Information Center (FCIC) at www.pueblo.gsa.gov. Limited quantities are available.
OWH Research
The joint conference entitled “Partnerships and Collaborations to Advance Patient Recruitment in Clinical Research” has been re-scheduled for October 14-15, 2010 at the Hilton Rockville Hotel. The conference collaboration aims to promote dialogue on the recruitment of
women in drug trials.
FDA Highlights
The FDA is asking for comments and information from the public and other interested parties about front-of-package nutrition labeling and on shelf tags in retail stores.
The FDA is seeking to learn more about
▪ the extent to which consumers notice, use and understand nutrition symbols on front-of-pack labeling of food packages or on shelf tags in retail stores
▪ research that assesses and compares the effectiveness of particular approaches to front-of-pack labeling
▪ graphic design, marketing and advertising data and information that can help develop better point-of-purchase nutrition information
▪ how point-of-purchase information may affect decisions by food manufacturers to reformulate products.
Comments will be accepted until July 28, 2010.
To Learn More: Federal Register Notice
On June 1, FDA approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures. Prolia works to decrease the destruction of bone and increase bone mass and strength. An injection of Prolia is recommended once every six months.
One out of every two women over age 50 will break a bone in their lifetime due to osteoporosis. People with osteoporosis at high risk for fracture include those that have had an osteoporotic fracture, or have multiple risk factors for fracture; or those who have failed or are intolerant to other available osteoporosis therapy.
For More Information:
▪ NIH Fast Facts on Osteoporosis
***************************
On May 26, 2010 FDA advised consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and Alli.
Both Xenical and Alli are medications that contain the same active ingredient, orlistat. Xenical is available only by prescription while Alli is sold over-the-counter without a prescription. An estimated 40 million people worldwide have taken either Xenical or Alli.
For More Information:
▪ FDA Drug Safety Communication on Orlistat
▪ FDA Questions and Answers about Orlistat
▪ Consumer Update: Weight-Loss Drugs and Risk of Liver Failure
Gestational Diabetes Campaign
To Learn More: "It's Never Too Early...to Prevent Diabetes"
OWH exhibits at conferences across the country to increase awareness of OWH programs and resources and to increase dissemination of the over 50 OWH fact sheets and brochures available for consumers. Visit the OWH exhibit booth at these upcoming conferences:
American Diabetes Association, June 25-28 –
National
International Society on Hypertension in Blacks, July 9-11 –
NAACP, July 10-15 –
American Association of Colleges of Pharmacy, July 10-14 –
National Council of La Raza , July 10-13 –
LULAC, July 12-17 –
National Association of Hispanic Nurses, July 21-24 –
National Urban League, July 27-31 –
Delta Sigma Theta National Convention, July 29-Aug 4 –
National Medical Association, Aug 1-3 –
American Association of Diabetes Educators, Aug 3-7 –
***************************
Free Publications for Women
Women’s Health Topics
Women’s Health Research
Advisory Committee Calendar
Recalls and Safety Alerts
Training and Continuing Education
FDA Newsroom
Office of Women’s Health
5600 Fishers Lane, HF-8
Rockville, MD 20857
301-827-0350
website: www.fda.gov/womens
Update your preferences or unsubscribe
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · 10903 New Hampshire Ave MD 20993 · 800-439-1420
